{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:49:16Z","timestamp":1791841756552,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128355","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T10:54:48Z","timestamp":1771412088000},"page":"128355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["What is the impact of the safety signal on dengue vaccination coverage among adolescents in Brazil?"],"prefix":"10.1016","volume":"77","author":[{"given":"Jadher","family":"Percio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Mendes Abreu","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s Mello","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cibelle Mendes","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Henrique Santos","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Dinamerica","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica Brauner","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariene Silva","family":"do Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayanne Concei\u00e7\u00e3o","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Catarina","family":"de Melo Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eder Gatti","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128355_bb0005","series-title":"Dengue - Global situation","author":"WHO Media Centre","year":"2023"},{"issue":"9966","key":"10.1016\/j.vaccine.2026.128355_bb0010","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue","volume":"385","author":"Guzman","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128355_bb0015","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0113-2024","article-title":"The greatest dengue epidemic in Brazil: surveillance, prevention, and control","volume":"57","author":"Gurgel-Gon\u00e7alves","year":"2024","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.vaccine.2026.128355_bb0020","unstructured":"Pasquini P, Antonio V, Pinhoni M. No Brasil, mortes por dengue em 2024 superam total dos oito anos anteriores. [Accessed onember 27, 2024]. Available at: https:\/\/www1.folha.uol.com.br\/equilibrioesaude\/2024\/12\/no-brasil-mortes-por-dengue-em-2024-superam-total-dos-oito-anos-anteriores.shtml."},{"key":"10.1016\/j.vaccine.2026.128355_bb0025","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Minist\u00e9rio da Sa\u00fade incorpora vacina contra a dengue no SUS [Internet]. [Bras\u00edlia]. 2023. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/2023\/dezembro\/ministerio-da-saude-incorpora-vacina-contra-a-dengue-no-sus."},{"key":"10.1016\/j.vaccine.2026.128355_bb0030","unstructured":"Brasil. Informe t\u00e9cnico-operacional: estrat\u00e9gia de vacina\u00e7\u00e3o contra a dengue \u2013 2024 [Internet]. 1st ed. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade., editor. Bras\u00edlia: 2024; 2024. 39 p. Available from: http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/informe_tecnico_estrategia_vacinacao_dengue_2024.pdf."},{"issue":"26","key":"10.1016\/j.vaccine.2026.128355_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126407","article-title":"Safety signal detected: anaphylaxis after attenuated dengue vaccine (TAK-003) - Brazil, march 1, 2023-march 11, 2024","volume":"42","author":"Percio","year":"2024","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128355_bb0040","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults","volume":"137","author":"McNeil","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128355_bb0045","first-page":"54","article-title":"Incidence of vaccine-related anaphylaxis from Brazil\u2019s National Immunization Program","volume":"8","author":"Hernandes","year":"2024","journal-title":"Arq Asmas Alerg e Imunol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128355_bb0050","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S2214-109X(23)00522-3","article-title":"Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4\u00b75-year results from a phase 3, randomised, double-blind, placebo-controlled trial","volume":"12","author":"Tricou","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128355_bb0055","unstructured":"Brasil. Nota T\u00e9cnica n\u00b0 7\/2024 - CGFAM\/DPNI\/SVSA\/MS [Internet]. Bras\u00edlia; 2024. Available from: https:\/\/www.gov.br\/saude\/pt-br\/centrais-de-conteudo\/publicacoes\/notas-tecnicas\/2024\/nota-tecnica-no-7-2024-cgfam-dpni-svsa-ms."},{"key":"10.1016\/j.vaccine.2026.128355_bb0060","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica. Censo Demogr\u00e1fico 2022. 2023. Available from: https:\/\/www.ibge.gov.br\/estatisticas\/sociais\/populacao\/22827-censo-demografico-2022.html?edicao=38166&t=resultados."},{"key":"10.1016\/j.vaccine.2026.128355_bb0065","unstructured":"Brasil. Nota T\u00e9cnica n\u00b0 110\/2024-DPNI\/SVSA\/MS [Internet]. Bras\u00edlia; 2024. Available from: https:\/\/infoms.saude.gov.br\/content\/Default\/SEI_MS-0042897772-NotaT\u00e9cnica(CoorteHPV).pdf."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128355_bb0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12879-024-10263-w","article-title":"Association between contextual factors and vaccine coverage against human papilomavirus in adolescents in the state of Minas Gerais, Brazil: global spatial regressions","volume":"25","author":"Luvisaro","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128355_bb0075","article-title":"Ades\u00e3o e impacto da campanha de vacina\u00e7\u00e3o contra o v\u00edrus do papiloma humano (HPV) sobre a sa\u00fade da popula\u00e7\u00e3o feminina atrav\u00e9s de uma an\u00e1lise comparativa das regi\u00f5es norte e sudeste do Brasil","volume":"42","author":"Sim\u00f5es","year":"2022","journal-title":"Clin Biomed Res"},{"key":"10.1016\/j.vaccine.2026.128355_bb0080","doi-asserted-by":"crossref","first-page":"E210001","DOI":"10.1590\/1980-549720210001","article-title":"Cobertura da vacina papilomav\u00edrus humano (HPV) no Brasil: heterogeneidade espacial e entre coortes et\u00e1rias","volume":"24","author":"Moura","year":"2021","journal-title":"Rev Bras Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128355_bb0085","unstructured":"Instituto de Pesquisa Econ\u00f4mica Aplicada (IPEA). Atlas da vulnerabilidade social nos munic\u00edpios brasileiros. Bras\u00edlia: IPEA; 2015. Available from: http:\/\/ivs.ipea.gov.br\/index.php\/pt\/."},{"key":"10.1016\/j.vaccine.2026.128355_bb0090","unstructured":"Instituto de Pesquisa Econ\u00f4mica Aplicada (IPEA). Consulta Mapa. Available from: https:\/\/ivs.ipea.gov.br\/#\/consulta-mapa."},{"key":"10.1016\/j.vaccine.2026.128355_bb0095","unstructured":"Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o Prim\u00e1ria \u00e0 Sa\u00fade (SAPS\/MS). Nota T\u00e9cnica N\u00b0 2\/2025-SAPS\/MS: Cobertura Potencial Estimada da Aten\u00e7\u00e3o Prim\u00e1ria \u00e0 Sa\u00fade (APS) no Sistema \u00danico de Sa\u00fade (SUS). 2025. Available from: https:\/\/egestorab.saude.gov.br\/image\/?file=20250407_O_SEI0047071175NT022025CoberturaPotencialEstimadadaAPSnoSUS_7580492751288227022.pdf."},{"key":"10.1016\/j.vaccine.2026.128355_bb0100","unstructured":"Minist\u00e9rio da Sa\u00fade. e-Gestor Aten\u00e7\u00e3o Prim\u00e1ria \u00e0 Sa\u00fade. Cobertura Potencial da APS (2021 - atual). Available from: https:\/\/relatorioaps.saude.gov.br\/cobertura\/ap."},{"key":"10.1016\/j.vaccine.2026.128355_bb0105","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Desafios log\u00edsticos na distribui\u00e7\u00e3o de vacinas [Internet]. [Bras\u00edlia]. 2024. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/2024\/abril\/desafios-logisticos-na-distribuicao-de-vacinas."},{"key":"10.1016\/j.vaccine.2026.128355_bb0110","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Sistema de Informa\u00e7\u00e3o do Programa Nacional de Imuniza\u00e7\u00f5es [Internet]. [Bras\u00edlia]. 2024. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/2024\/maio\/sistema-de-informacao-do-programa-nacional-de-imunizacoes."},{"key":"10.1016\/j.vaccine.2026.128355_bb0115","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Prioriza\u00e7\u00e3o local nas campanhas de vacina\u00e7\u00e3o [Internet]. [Bras\u00edlia]. 2024. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/2024\/junho\/priorizacao-local-nas-campanhas-de-vacinacao."},{"issue":"spe","key":"10.1016\/j.vaccine.2026.128355_bb0120","doi-asserted-by":"crossref","DOI":"10.1590\/1518-8345.6296.3834","article-title":"Vaccination against human papillomavirus in Brazilian schoolchildren: National Survey of school health, 2019","volume":"30","author":"Silva","year":"2022","journal-title":"Rev Lat Am Enfermagem"},{"key":"10.1016\/j.vaccine.2026.128355_bb0125","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Programa de vacina\u00e7\u00e3o escolar contra o HPV [Internet]. [Bras\u00edlia]. 2014. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/programa-de-vacinacao-escolar-contra-o-hpv."},{"key":"10.1016\/j.vaccine.2026.128355_bb0130","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Introdu\u00e7\u00e3o da vacina contra o HPV no calend\u00e1rio de imuniza\u00e7\u00e3o de adolescentes [Internet]. [Bras\u00edlia]. 2014. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/introducao-da-vacina-contra-o-hpv-no-calendario-de-imunizacao-de-adolescentes."},{"key":"10.1016\/j.vaccine.2026.128355_bb0135","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Alcance de 100% de cobertura na vacina\u00e7\u00e3o contra o HPV [Internet]. [Bras\u00edlia]. 2014. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/alcance-de-100-de-cobertura-na-vacinacao-contra-o-hpv."},{"issue":"52","key":"10.1016\/j.vaccine.2026.128355_bb0140","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1016\/j.vaccine.2016.10.039","article-title":"Vaccine safety evaluation: practical aspects in assessing benefits and risks","volume":"34","author":"Di Pasquale","year":"2016","journal-title":"Vaccine"},{"issue":"34","key":"10.1016\/j.vaccine.2026.128355_bb0145","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128355_bb0150","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.08.020312","article-title":"Dengvaxia controversy: impact on vaccine hesitancy","volume":"8","author":"Fatima","year":"2018","journal-title":"J Glob Health"},{"issue":"43","key":"10.1016\/j.vaccine.2026.128355_bb0155","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1016\/j.vaccine.2020.08.044","article-title":"Immunization stress-related responses presenting as psychogenic non-epileptic seizures following HPV vaccination in Rio Branco, Brazil","volume":"38","author":"Marchetti","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128355_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS ONE"},{"issue":"23","key":"10.1016\/j.vaccine.2026.128355_bb0165","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel","volume":"385","author":"Mevorach","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.vaccine.2026.128355_bb0170","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2026.128355_bb0175","doi-asserted-by":"crossref","first-page":"B73","DOI":"10.1016\/j.vaccine.2012.11.036","article-title":"The imperative for stronger vaccine supply and logistics systems","volume":"31","author":"Zaffran","year":"2013","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128355_bb0180","article-title":"HPV vaccination coverage in Brazil\u2019s state of Paran\u00e1: spatial distribution and advances in public health","volume":"12","author":"Pelloso","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128355_bb0185","doi-asserted-by":"crossref","DOI":"10.1590\/1413-81232024298.03952023","article-title":"Spatial clusters and social inequities in COVID-19 vaccine coverage among children in Brazil","volume":"29","author":"Boing","year":"2024","journal-title":"Cienc Saude Coletiva"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128355_bb0190","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1158\/1055-9965.EPI-21-0331","article-title":"Identifying area-level disparities in human papillomavirus vaccination coverage using geospatial analysis","volume":"30","author":"Wheeler","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128355_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-74982-5","article-title":"Modelling the spatial variability and uncertainty for under-vaccination and zero-dose children in fragile settings","volume":"14","author":"Alegana","year":"2024","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:27:27Z","timestamp":1776148047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":39,"alternative-id":["S0264410X26001635"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128355","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is the impact of the safety signal on dengue vaccination coverage among adolescents in Brazil?","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128355"}}